Provoking cancer cell cuproptosis breaks radiotherapy resistance

Radiation induces multiple forms of cell death that critically govern therapeutic efficacy and antitumor immunity. Although apoptosis is the primary cell death pathway mediated by radiation, it paradoxically promotes immune evasion and radioresistance. This underscores the need to identify dominant cell death pathways underlying radioresistance to address clinical radiotherapy bottlenecks. In the current issue of Cancer Cell, Lei et al. demonstrate that radiation-induced ​​cuproptosis​​ is a mechanism to overcome radioresistance. Here, we focus on the emerging cross-talk between radiotherapy and cuproptosis evasion, discuss immunomodulatory death pathway networks in radiotherapy, and also emphasize that future studies should elucidate the role of cuproptosis in orchestrating radiotherapy-induced immune responses.

Authors

Institutions

Publication Details

Journal
Immunity & Inflammation
Published
2025-12-25
DOI
https://doi.org/10.1007/s44466-025-00016-y
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Provoking cancer cell cuproptosis breaks radiotherapy resistance

Chuanhui Han, Yang Pu, Huizhu Chen
Immunity & Inflammation
Cancer Immunotherapy and Biomarkers
article

Provoking cancer cell cuproptosis breaks radiotherapy resistance

Chuanhui Han, Yang Pu, Huizhu Chen
article en

Abstract

Radiation induces multiple forms of cell death that critically govern therapeutic efficacy and antitumor immunity. Although apoptosis is the primary cell death pathway mediated by radiation, it paradoxically promotes immune evasion and radioresistance. This underscores the need to identify dominant cell death pathways underlying radioresistance to address clinical radiotherapy bottlenecks. In the current issue of Cancer Cell, Lei et al. demonstrate that radiation-induced ​​cuproptosis​​ is a mechanism to overcome radioresistance. Here, we focus on the emerging cross-talk between radiotherapy and cuproptosis evasion, discuss immunomodulatory death pathway networks in radiotherapy, and also emphasize that future studies should elucidate the role of cuproptosis in orchestrating radiotherapy-induced immune responses.

Immunity & InflammationVol. 1(1)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking University (CN), Peking University Cancer Hospital (CN), Peking University First Hospital (CN)
National Natural Science Foundation of China, National Key Research and Development Program of China
Good health and well-being
Openalex Percentile: Top 31%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.